Chemoinformaics analysis of 1,2-Dimethylpropyl 2-ethylhexanoate
| Molecular Weight | 214.349 | nRot | 7 |
| Heavy Atom Molecular Weight | 188.141 | nRig | 1 |
| Exact Molecular Weight | 214.193 | nRing | 0 |
| Solubility: LogS | -4.507 | nHRing | 0 |
| Solubility: LogP | 4.381 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 41 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 15 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 26 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 13 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 40.6506 |
| nHD | 0 | BPOL | 28.6874 |
| QED | 0.603 |
| Synth | 3.147 |
| Natural Product Likeliness | 0.943 |
| NR-PPAR-gamma | 0.006 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.425 |
| Pgp-sub | 0.003 |
| HIA | 0.004 |
| CACO-2 | -4.344 |
| MDCK | 0.0000232 |
| BBB | 0.624 |
| PPB | 0.948656 |
| VDSS | 0.522 |
| FU | 0.0413623 |
| CYP1A2-inh | 0.514 |
| CYP1A2-sub | 0.426 |
| CYP2c19-inh | 0.186 |
| CYP2c19-sub | 0.882 |
| CYP2c9-inh | 0.552 |
| CYP2c9-sub | 0.402 |
| CYP2d6-inh | 0.162 |
| CYP2d6-sub | 0.101 |
| CYP3a4-inh | 0.559 |
| CYP3a4-sub | 0.384 |
| CL | 11.225 |
| T12 | 0.469 |
| hERG | 0.006 |
| Ames | 0.006 |
| ROA | 0.015 |
| SkinSen | 0.328 |
| Carcinogencity | 0.127 |
| EI | 0.978 |
| Respiratory | 0.365 |
| NR-Aromatase | 0.003 |
| Antiviral | Yes |
| Prediction | 0.777219 |